These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34973275)

  • 1. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
    Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGB3 inhibition by miR-142-3p/sh-RNA modulates autophagy and induces apoptosis via ROS accumulation and mitochondrial dysfunction and reduces the tumorigenic potential of human breast cancer cells.
    Sharma P; Yadav P; Sundaram S; Venkatraman G; Bera AK; Karunagaran D
    Life Sci; 2022 Sep; 304():120727. PubMed ID: 35753437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
    Xiong L; Tang Y; Tang J; Liu Z; Wang X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Br J Cancer; 2016 Sep; 115(6):741-51. PubMed ID: 27537384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
    Liu X; Xie S; Zhang J; Kang Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
    [No Abstract]   [Full Text] [Related]  

  • 7. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting HMGA1.
    Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
    Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-204-3p represses colon cancer cells proliferation, migration, and invasion by targeting HMGA2.
    Xi X; Teng M; Zhang L; Xia L; Chen J; Cui Z
    J Cell Physiol; 2020 Feb; 235(2):1330-1338. PubMed ID: 31286521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Luan Q; Yang R; Lin L; Li X
    Can J Physiol Pharmacol; 2022 Feb; 100(2):158-166. PubMed ID: 35080988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
    Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
    Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0000511 Improves Epithelial Mesenchymal Transition of Cervical Cancer by Regulating hsa-mir-296-5p/HMGA1.
    Xie J; Chen Q; Zhou P; Fan W
    J Immunol Res; 2021; 2021():9964538. PubMed ID: 34136582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p.
    Zhong J; He C; Xu F; Xu X; Liu L; Xu M; Guo Z; Wang Y; Liao J; Li Y
    J Orthop Surg Res; 2020 Sep; 15(1):374. PubMed ID: 32883329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
    Zhu J; Han S
    Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST8SIA6-AS1 contributes to hepatocellular carcinoma progression by targeting miR-142-3p/HMGA1 axis.
    Feng T; Yao Y; Luo L; Zou H; Xiang G; Wei L; Yang Q; Shi Y; Huang X; Lai C
    Sci Rep; 2023 Jan; 13(1):650. PubMed ID: 36635290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
    Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
    Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.